Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
3.100
-0.150 (-4.62%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $21.56 million as of July 2, 2024. Its market cap has increased by 79.70% in one year.
Market Cap
21.56M
Enterprise Value
20.25M
1-Year Change
79.70%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since January 6, 2014, Akari Therapeutics,'s market cap has increased from $10.70M to $21.56M, an increase of 101.53%. That is a compound annual growth rate of 6.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 25.50M | 61.39% |
| Dec 29, 2023 | 15.80M | -43.37% |
| Dec 30, 2022 | 27.90M | -60.92% |
| Dec 31, 2021 | 71.40M | 13.88% |
| Dec 31, 2020 | 62.70M | 70.38% |
| Dec 31, 2019 | 36.80M | 53.33% |
| Dec 31, 2018 | 24.00M | -52.94% |
| Dec 29, 2017 | 51.00M | -38.48% |
| Dec 30, 2016 | 82.90M | -51.46% |
| Dec 31, 2015 | 170.80M | 784.97% |
| Dec 31, 2014 | 19.30M | 80.37% |
| Jan 6, 2014 | 10.70M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OneMedNet | 21.75M |
| Nephros | 21.72M |
| Spruce Biosciences | 21.70M |
| Renalytix | 21.63M |
| Gain Therapeutics | 21.57M |
| Minerva Neurosciences | 21.54M |
| ATI Physical Therapy | 21.49M |
| Apollomics | 21.09M |